Search Results - "Dandana, A"

Maturity Onset Diabetes of the Young (MODY) in Tunisia: Low frequencies of GCK and HNF1A mutations by Ben Khelifa, S., Martinez, R., Dandana, A., Khochtali, I., Ferchichi, S., Castaño, L.

“…Maturity Onset Diabetes of the Young (MODY) is a monogenic form of diabetes characterized by autosomal dominant inheritance, an early clinical onset and a…”
Get full text

Mucopolysaccharidosis IVA within Tunisian patients: Confirmation of the two novel GALNS gene mutations by Khedhiri, S., Chkioua, L., Bouzidi, H., Dandana, A., Ferchichi, S., Ben Turkia, H., Miled, A., Laradi, S.

“…Mucopolysaccharidosis type IVA or Morquio A disease is an autosomal recessive disease resulting from a deficiency of the lysosomal enzyme…”
Get full text

Study of the intronic polymorphism of the angiotensin 1 converting enzyme among coronary Tunisians by Chalghoum, A, Noichri, Y, Chkioua, L, Gammoudi, I, Dandana, A, Chahed, H, Khelil, S, Jeridi, G, Baudin, B, Ferchichi, S, Miled, A

“…The acute coronary syndromes (ACS) are classified among the major causes of mortality in the industrialized countries. The increased angiotensin I converting…”
Get more information

Mucopolysaccharidosis type I: identification of alpha-L-iduronidase mutations in Tunisian families by Chkioua, L, Khedhiri, S, Jaidane, Z, Ferchichi, S, Habib, S, Froissart, R, Bonnet, V, Chaabouni, M, Dandana, A, Jrad, T, Limem, H, Maire, I, Abdelhedi, M, Laradi, S

“…Mucopolysaccharidosis type I (MPS I) is a lysosomal disease due to mutations in the gene encoding alpha-l-iduronidase (IDUA) leading to variable clinical…”
Get full text

Mucopolysaccharidoses type I and IVA: Clinical features and consanguinity in Tunisia by Khedhiri, S., Chkioua, L., Bouzidi, H., Dandana, A., Ben Turkia, H., Miled, A., Laradi, S.

“…Mucopolysaccharidoses (MPS) are a group of lysosomal storage disorders caused by the deficiency of specific enzymes which leads to the lysosomal accumulation…”
Get full text

Assessment of Medication Prescribing Pattern in COVID-19 Admitted Patients by Using WHO Prescribing Indicators at Eka Kotebe General Hospital, Addis Ababa, Ethiopia; Retrospective Cross-Sectional Study by Birhanu, Belete, Debebe, Solomon, Nigussie, Tsegaye, Dandana, Alemayehu

“…Introduction: Drug therapy is a crucial component of health care and plays a vital role in preserving life. However, the irrational utilization of medications…”
Get full text

Biochemical and molecular diagnosis of Gaucher disease in Tunisia by Dandana, A, Ferchichi, S, Khedhiri, S, Chkioua, L, Jaidane, Z, Monastiri, K, Ben Khelifa, S, Ben Mansour, R, Maire, I, Froissart, R, Bonnet, V, Laradi, S, Miled, A

“…Our study was carried out at a family from the Sahel (Tunisia). The father (index case) and his two children (son and daughter). The father…”
Get more information

Diagnostic strategy of mucopolysaccharidosis type I in Tunisia by Chkioua, L, Ferchichi, S, Khedhiri, S, Laradi, S, Bibi, A, Amira, D, Dandana, A, Ben Mansour, R, Ben Limam, H, Chaabouni, M, Froissart, R, Maire, I, Miled, A

“…A Tunisian patient affected by mucopolysaccharidosis (MPS) was investigated for a biological analysis (quantitative and qualitative glycosaminoglycans (GAG)…”
Get more information

Molecular analysis of the p.Asn 370 Ser mutation in Gaucher disease by Dandana, A, Ferchichi, S, Ben Khelifa, S, Jaidane, Z, Monastiri, K, Chkioua, L, Maire, I, Froissart, R, Bonnet, V, Laradi, S, Miled, A

“…Gaucher disease is one of the most prevalent lysosomal disorders. In this present study, we report a diagnostic strategy of type 1 Gaucher disease. The…”
Get full text

Étude du polymorphisme intronique de l’enzyme de conversion de l’angiotensine I chez des coronariens tunisiens by Chalghoum, A., Noichri, Y., Chkioua, L., Gammoudi, I., Dandana, A., Chahed, H., Khelil, S., Jeridi, G., Baudin, B., Ferchichi, S., Miled, A.

“…Les syndromes coronariens aigus (SCA) sont classés parmi les causes majeures de mortalité dans les pays industrialisés. L’élévation de l’activité de l’enzyme…”
Get full text

Le peptide natriurétique type B (BNP) chez les insuffisants cardiaques tunisiens by Jaidane, Z., Ferchichi, S., Dandana, A., Chahed, H., Ben Limem, H., Bouraoui, H., Ammar, H., Miled, A.

“…Heart failure is a major public health problem and despite significant advances in treatment remains the only cardiovascular disease still on the rise. It has…”
Get full text

Hyperhomocystéinémie et stress oxydant chez les insuffisants cardiaques by Khelil, S., Ferchichi, S., Gammoudi, I., Jaidane, Z., Chahed, H., Dandana, A., Noichri, Y., Chalghoum, A., Ernez, S., Jeridi, G., Miled, A.

“…An imbalance between production of free radicals and oxidative protection in association with the coronary decease and their consequences such heart failure…”
Get full text

Étude des marqueurs du stress oxydatif chez les coronariens tabagiques tunisiens by Gammoudi, I., Khelil, S., Dandana, A., Jaidane, Z., Chalghoum, A., Noichri, Y., Chahed, H., Chaabouni, Y., Ernez, S., Jeridi, G., Ferchichi, S., Miled, A.

“…The present study was undertaken to evaluate the variation of the parameters of antioxidant and oxidant status in coronary smokers Tunisian patients. We made…”
Get full text

La mucopolysaccharidose de type I : identification des mutations du gène alpha-L-iduronidase dans des familles tunisiennes by Chkioua, L., Khedhiri, S., Jaidane, Z., Ferchichi, S., Habib, S., Froissart, R., Bonnet, V., Chaabouni, M., Dandana, A., Jrad, T., Limem, H., Maire, I., Abdelhedi, M., Laradi, S.

“…La mucopolysaccharidose de type I (MPS I) est une maladie de surcharge lysosomale, due au déficit en α-L-iduronidase (IDUA). C'est une maladie grave avec un…”
Get full text

Pathological interactions between the endothelin-1 and the angiotensin- converting enzyme among Tunisian coronary patients by Chalghoum, Abdelkader, Noichri, Yosri, Dandana, Azza, Baudin, Bruno, Miled, Abdelhédi, Ferchichi, Salima

“…The correct understanding of the biochemical and metabolic interactions between coronary risk factors contribute to the exploration of cardiovascular…”
Get full text

Analyse moléculaire de la mutation p.Asn 370 Ser dans la maladie de Gaucher by Dandana, A., Ferchichi, S., Ben Khelifa, S., Jaidane, Z., Monastiri, K., Chkioua, L., Maire, I., Froissart, R., Bonnet, V., Laradi, S., Miled, A.

“…La maladie de Gaucher est la plus fréquente des maladies génétiques lysosomales. Dans cette étude, nous avons essayé d’appliquer une stratégie diagnostique de…”
Get full text

Évaluation des paramètres du stress oxydant chez des patients coronariens by Gammoudi, I., Dandana, A., Chahed, H., Ferchichi, S., Ernez, S., Miled, A.

“…The present study was undertaken to evaluate the variation of the parameters of antioxidant and oxidant status in coronary patients. Two hundred and eighteen…”
Get full text

Le peptide natriurétique de type B (BNP) et l’enzyme de conversion de l’angiotensine 1 (ECA1) chez les coronariens tunisiens by Chalghoum, A., Noichri, Y., Dandana, A., Gammoudi, I., Khelil, S., Ferchichi, S., Miled, A.

“…Acute coronary syndrome is a clinical and complex entity; brain natriuretic peptide (BNP) and angiotensin-1 converting enzyme (ACE1) constitute unconventional…”
Get full text

Intérêt du dosage de la cystatine C chez des patients coronariens tunisiens by Dandana, A., Gammoudi, I., Chahed, H., Ferchichi, S., Maatouk, F., Miled, A.

“…The cystatin C is a new marker to evaluate the kidney function. The objective of our study is to check the implication of the cystatin C in the evaluation of…”
Get full text

Évaluation du taux d’uricémie et du statut antioxydant total chez des patients tunisiens présentant un infarctus du myocarde by Noichri, Y., Chalghoum, A., Chahed, H., Khelil, S., Dandana, A., Gammoudi, I., Boughzala, E., Ferchichi, S., Miled, A.

Get full text